- Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer2020 | Lékařská fakulta v Hradci Králové
- Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years2020 | Lékařská fakulta v Hradci Králové
- Plasma filtration for the controlled removal of liposomal therapeutics - From the apheretic site of view2017 | Lékařská fakulta v Hradci Králové
- Plasmafiltration as a possible contributor to kinetic targeting of pegylated liposomal doxorubicin (PLD) in order to prevent organ toxicity and immunosuppression2016 | Lékařská fakulta v Hradci Králové